Evidence map›Paper›PMID 19541535›Full record

ReviewTrends in immunology2009

Human innate immunosenescence: causes and consequences for immunity in old age.

Alexander Panda, Alvaro Arjona, Elizabeth Sapey, Fengwei Bai, Erol Fikrig, Ruth R Montgomery, Janet M Lord, Albert C Shaw

Open access · greenAbstract readReview
In one paragraph

Review in Trends in immunology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 204 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
204citing papers in PubMed, 2 pooled it
25.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

204 citing papers in PubMed, 2 syntheses or guidelines pooled it, 513 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. American Ginseng (Current issues in molecular biology · 2026
    Article
  19. Article
  20. Article

144 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Alexander PandaSection of Infectious Diseases, Yale University School of Medicine, New Haven, CT 06520, USA.
Alvaro Arjona
Elizabeth Sapey
Fengwei Bai
Erol Fikrig
Ruth R Montgomery
Janet M Lord
Albert C Shaw
Yale University · USUniversity of Birmingham · GB

Funding

Yale Study Support Suite (YES3): Dashboard and Web Portal Software Supporting Research Workflow through integrated, customizable REDCap External ModulesP30AG021342 · NIA · YALE UNIVERSITY · PI Denise Esserman · 2002 to 2026
$37.9M
Immunotherapeutics for Treatment of Flavivirus InfectionU01AI070343 · NIAID · YALE UNIVERSITY · PI FIKRIG, EROL · 2006 to 2010
$6.6M
IMMUNE FUNCTION AND BIODEFENSE IN CHILDREN. ELDERLY AND IMMUNOCOMPROMI-266050031N01AI050031 · NIAID · EMORY UNIVERSITY · PI LARSEN, CHRISTOPHER · 2006 to 2006
–
Howard Hughes Medical InstituteNIAID NIH HHS AI 070343NIAID NIH HHS N01 AI050031NIAID NIH HHS N01 AI500031NIAID NIH HHS N01-AI-50031NIAID NIH HHS U01 AI070343NIA NIH HHS P30 AG021342
6 · The paper itself

Abstract

The past decade has seen an explosion in research focusing on innate immunity. Through a wide range of mechanisms including phagocytosis, intracellular killing and activation of proinflammatory or antiviral cytokine production, the cells of the innate immune system initiate and support adaptive immunity. The effects of aging on innate immune responses remain incompletely understood, particularly in humans. Here we review advances in the study of human immunosenescence in the diverse cells of the innate immune system, including neutrophils, monocytes, macrophages, natural killer and natural killer T (NKT) cells and dendritic cells-with a focus on consequences for the response to infection or vaccination in old age.

Indexed as

Immunity, InnateAgedAged, 80 and overAgingBasophilsCytokinesDendritic CellsEosinophilsHumansKiller Cells, NaturalMacrophagesNatural Killer T-CellsNeutrophilsSignal TransductionToll-Like ReceptorsCytokinesToll-Like Receptors

Identifiers

PMID19541535
PMCPMC4067971
OpenAlexW2044159907

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.